Atlas Venture
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
- United States
Investment stages
- Series A
- Growth
Industries
- Biotechnology
- Digital Health
- Health Tech
About
Atlas Venture provides significant capital support to biotech ventures, helping them scale through clinical development and commercialization. The firm leverages its deep industry expertise and network to accelerate the growth of leading U.S. therapeutics companies.
Atlas Venture provides significant capital support to biotech ventures, helping them scale through clinical development and commercialization. The firm leverages its deep industry expertise and network to accelerate the growth of leading U.S. therapeutics companies.
Investment Thesis
Atlas Venture invests in Series A and growth-stage biotech startups, focusing on breakthrough therapeutics and category-defining companies. The firm looks for high-impact innovations in life sciences with strong clinical potential.
Manager's Experience
Focused on early-stage investments across technology and healthcare sectors. With deep experience in the North American market, successfully closed over 50 deals with a notable number of exits. Specializes in growth equity, employing a hands-on approach to drive operational improvements. Recognized for a robust track record in fostering innovation and delivering exceptional returns.
Team
Maurizio Fazio – Principal
Peter Barrett – Partner (Legacy Funds)
David Grayzel – Partner
Jean-François Formela – Partner
Bruce Booth – Partner
Michael Gladstone – Partner
Kevin Bitterman – Partner
Aimee Raleigh – Principal
Chelsea Place Johnson – Principal
Julia Pian – Associate
Jason Rhodes – Partner
Jernej Godec – Principal
Justin Feng – Senior Associate